Fields »

GENE AND PROTEIN SUMMARY

? »

Gene name

NFKB1

Description

nuclear factor of kappa light polypeptide gene enhancer in B-cells 1

Protein class

Candidate cancer biomarkers, Mapped to UniProt SWISS-PROT, Potential transmembrane proteins, Transcription factors

Protein evidence

High

Entrez gene summary

This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]

External links

Ensembl, UniProt, Entrez gene, neXtProt, Antibodypedia

No of splice variants

7 in total
0 with predicted TM region
0 with predicted signal peptide

SUBCELLULAR LOCATION SUMMARY

? »

Show image »

Main location(s)

Nucleus but not nucleoli

Additional location(s)

Cytoplasm 

Staining summary

Mainly localized to the nucleus. In addition localized to the cytoplasm.

Reliability (APE)

Medium

Antibodies in assay

CAB004031, HPA027305
 

NORMAL TISSUE & ORGAN SUMMARY

? »

Show image »

Expression summary

Ubiquitous nuclear and cytoplasmic expression, most abundant in lymphoid tissues.

Tissue specificity

Expressed in 40 out of 82 cell types

Reliability (APE)

Medium

Antibodies in assay

CAB004031, HPA027305
 

Organ

No of cell types

Protein expression

CNS (brain) 11
Hematopoietic (blood) 8
Liver and pancreas 5
Digestive (GI-tract) 13
Respiratory (lung) 4
Cardiovascular 1
Female tissues 13
Placenta 2
Male tissues 5
Urinary tract (kidney) 3
Skin and soft tissues 14
Endocrine tissues 3

Level of annotated protein expression





High
Medium
Low
None

CANCER TISSUE SUMMARY

? »

Staining summary

Antibody staining in 49% of the cancers

Antibodies in assay

CAB004031, HPA027305
 

Tissue

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Tissue

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Level of antibody staining





Strong
Moderate
Weak
Negative

CELL LINE SUMMARY

? »

RNA evidence

High
 

Cell line

Cell origin

RNA abundance

IH staining

IF intensity

CAB004031

HPA027305

CAB004031

HPA027305

A-431 Skin High
NegativeWeak
A-549 Lung Medium
CACO-2 Colon Medium
HEK 293 Embryonal kidney Medium
HeLa Cervix Medium
Hep-G2 Liver Medium
MCF-7 Pleural effusion Medium
PC-3 Bone marrow Medium
RT-4 Urinary bladder High
U-2 OS Bone Medium
NegativeStrong
U-251 MG Brain Medium
NegativeWeak

ANTIBODY SUMMARY

? »

Antibody

Clonality

Validation

CAB004031 pAb
HPA027305 pAb